Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Election of New Director
Health Company (the
as a Class III Director, effective as of
Company’s 2024 Annual Meeting of Stockholders and until her successor is duly
elected and qualified. The Board has not determined committee appointments for
There are no transactions between
reportable under Item 404(a) of Regulation S-K. Ms. Beck’s compensation will be
consistent with the Company’s previously disclosed standard compensatory
arrangements for non-employee directors, which are described in the Company’s
Annual Report on Form 10-K filed with the
agreement, a form of which was filed as Exhibit 10.13 to the Company’s Current
Report on Form 8-K filed with the
Item 7.01 Regulation FD Disclosure.
hereto as Exhibit 99.1 and is incorporated herein by reference.
Exhibit 99.1 contains forward-looking statements. These forward-looking
statements are not guarantees of future performance and involve risks,
uncertainties, and assumptions that are difficult to predict. Forward-looking
statements are based upon assumptions as to future events that may not prove to
be accurate. Actual outcomes and results may differ materially from what is
expressed in these forward-looking statements.
The information set forth under Item 7.01 of this Current Report, including
Exhibit 99.1 attached hereto, is being furnished and shall not be deemed “filed”
for purposes of Section 18 of the Securities Exchange Act of 1934, as amended
(the “Exchange Act”), or otherwise subject to the liabilities of such section.
The information in Item 7.01 of this Current Report, including Exhibit 99.1,
shall not be incorporated by reference into any filing under the Securities Act
of 1933, as amended, or the Exchange Act, regardless of any incorporation by
reference language in any such filing, except as expressly set forth by specific
reference in such a filing. This Current Report will not be deemed an admission
as to the materiality of any information in this Current Report that is required
to be disclosed solely by Regulation FD.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits. Exhibit No. Description 99.1 Press Release, dated
June 6, 2022104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
© Edgar Online, source